Population pharmacokinetic and pharmacodynamic modeling of evobrutinib in healthy adult participants

Abstract Evobrutinib, a Bruton's tyrosine kinase (BTK) inhibitor, has shown therapeutic potential in relapsing multiple sclerosis. This analysis aimed to develop pharmacokinetic (PK) and pharmacodynamic (PD; BTK occupancy [BTKO]) models of evobrutinib and simulate PK and BTKO profiles under alt...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Orestis Papasouliotis (Author), David Mitchell (Author), Pascal Girard (Author), Martin Dyroff (Author)
Formato: Livro
Publicado em: Wiley, 2022-12-01T00:00:00Z.
Assuntos:
Acesso em linha:Connect to this object online.
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

Connect to this object online.

3rd Floor Main Library

Detalhes do Exemplar 3rd Floor Main Library
Área/Cota: A1234.567
Cód. Barras: 1 Disponível